ServicenavigationHauptnavigationTrailKarteikarten


Forschungsstelle
INNOSUISSE
Projektnummer
35449.1 IP-LS
Projekttitel
Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases
Projekttitel Englisch
Non-competitive pharmacologic chaperones developed through the Site-directed Enzyme Enhancement Therapy (SEE-Tx) technology for the treatment of rare genetic and neurodegenerative diseases

Beteiligte

Bundesstelle/ Verwaltungseinheit Innosuisse
Schweizerische Agentur
für Innovationsförderung
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Zentrale)
info@innosuisse.ch
www.innosuisse.ch/
Kontaktperson

Maurizio Molinari
Istituto di Ricerca in Biomedicina
via Francesco Chiesa 5
CH-6500 Bellizona
+41 91 820 0319
maurizio.molinari@irb.usi.ch


Wirtschaftspartner

Manolo Bellotto
Gain Therapeutics SA
GT
CHE-438.987.642
Via Peri 9D
CH-6900 Lugano
+41 91 921 15 24
mbellotto@gaintherapeutics.com